Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Trump says US will intervene if Iran starts...
JONATHAN TURLEY: Trump’s Kennedy Center name change will...
President Trump is a generational talent just like...
Here are the key 2026 House and Senate...
Trump claims White House doctors report him in...
Trump regrets handing Dems health ‘ammunition’ with October...
Iran crackdown rattles Middle East as analysts weigh...
Beyond HODL: Why the DeFi Technologies Lawsuit Signals...
Josef Schachter: Oil Stock Buy Signal Approaching, 3...
Bold Ventures Closes $776,800 Non-Brokered Private Placement
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
The Hitchhiker’s Guide to where we stand to avoid a government shutdown
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

The unnoticed election that could determine the future

October 16, 2024

Trump isn’t the first president menaced by Derangement...

October 26, 2024

Bill Barr transcript flies in face of Democrat...

September 16, 2025

Trump’s ‘big, beautiful bill’ stalls in House amid...

July 3, 2025

Biden travels to Africa where policies were ‘over-promised...

December 2, 2024

Trump foe Letitia James leading charge on new...

May 6, 2025

Trump blasts Biden’s DOJ: They tried to turn...

March 15, 2025

Joe Biden poses with Hunter’s Chinese business associates...

December 27, 2024

Dems eerily silent on Trump sentencing as they...

January 11, 2025

BROADCAST BIAS: ABC compares Sydney Sweeney ad to...

August 2, 2025

Recent Posts

  • Trump says US will intervene if Iran starts killing protesters: ‘Locked and loaded’
  • JONATHAN TURLEY: Trump’s Kennedy Center name change will keep lawyers busy for years
  • President Trump is a generational talent just like our most gifted athletes
  • Here are the key 2026 House and Senate races to watch that could decide control of Congress
  • Trump claims White House doctors report him in ‘perfect health,’ says he ‘aced’ third straight cognitive exam

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (964)
    • Investing (3,783)
    • Politics (4,565)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.